Dyslipidemia Collection
 1-20 of 50 Articles
ACP Journal Club |  17 November 2015
ACC/AHA guidelines determining statin eligibility better predicted CVD than ATP-III guidelines
Raul D. Santos, MD, PhD, MSc
Ann Intern Med. 2015;163(10):JC11. doi:10.7326/ACPJC-2015-163-10-011
ACP Journal Club |  15 September 2015
Adding ezetimibe to simvastatin improved cardiovascular outcomes in stable acute coronary syndrome
Christopher B. Fordyce, MD, MSc; Christopher B. Granger, MD
Ann Intern Med. 2015;163(6):JC7. doi:10.7326/ACPJC-2015-163-6-007
ACP Journal Club |  18 August 2015
In palliative care, discontinuation of statins did not differ from continuation for mortality
Martin Stockler, MD
Ann Intern Med. 2015;163(4):JC7. doi:10.7326/ACPJC-2015-163-4-007
ACP Journal Club |  19 May 2015
Review: Statins do not increase adverse cognitive effects in patients with or without initial cognitive impairment
Steven M. Belknap, MD, FACP, FCP
Ann Intern Med. 2015;162(10):JC6. doi:10.7326/ACPJC-2015-162-10-006
ACP Journal Club |  17 February 2015
Review: Periprocedural high-dose statins reduce contrast-induced acute kidney injury after coronary angiography
Richard G. Bach, MD
Ann Intern Med. 2015;162(4):JC4. doi:10.7326/ACPJC-2015-162-4-004
ACP Journal Club |  16 December 2014
Review: In adult outpatients, nurse-managed protocols improve hemoglobin A1c levels and blood pressure
Kevin A. Schulman, MD
Ann Intern Med. 2014;161(12):JC6. doi:10.7326/0003-4819-161-12-201412160-02006
ACP Journal Club |  18 November 2014
Review: Statins before coronary catheterization reduce contrast-induced acute kidney injury
Himanshu Aggarwal, MD, MPH; Brigitta C. Brott, MD
Ann Intern Med. 2014;161(10):JC7. doi:10.7326/0003-4819-161-10-201411180-02007
ACP Journal Club |  18 November 2014
Adding niacin plus laropiprant to statins did not reduce vascular events and increased serious adverse events
Hanna E. Bloomfield, MD, MPH
Ann Intern Med. 2014;161(10):JC8. doi:10.7326/0003-4819-161-10-201411180-02008
ACP Journal Club |  21 October 2014
Pooled RCTs: Atorvastatin did not increase renal-related serious adverse events
William Herrington, MD; Richard Haynes, MD
Ann Intern Med. 2014;161(8):JC8. doi:10.7326/0003-4819-161-8-201410210-02008
ACP Journal Club |  19 August 2014
ACC/AHA Pooled Cohort Risk Equations predicted 5-y risk for CV events in adults considered for statin initiation
Ann Marie Navar-Boggan, MD, PhD; L. Kristin Newby, MD, MHS
Ann Intern Med. 2014;161(4):JC12. doi:10.7326/0003-4819-161-4-201408190-02012
ACP Journal Club |  15 July 2014
Review: Statins do not increase minor or serious symptomatic adverse events in placebo-controlled trials
Meera Jain, MD; Richard Wernick, MD
Ann Intern Med. 2014;161(2):JC3. doi:10.7326/0003-4819-161-2-201407150-02003
ACP Journal Club |  20 May 2014
Review: In older patients without CVD, statins reduce MI and stroke but not all-cause mortality
Saul Schaefer, MD
Ann Intern Med. 2014;160(10):JC8. doi:10.7326/0003-4819-160-10-201405200-02008
ACP Journal Club |  20 May 2014
Early high-dose rosuvastatin prevented contrast-induced acute kidney injury in non–ST-elevation ACS
Amber O. Molnar, MD; Amit X. Garg, MD
Ann Intern Med. 2014;160(10):JC9. doi:10.7326/0003-4819-160-10-201405200-02009
ACP Journal Club |  20 May 2014
Review: Statins are not associated with cognitive impairment, Alzheimer disease, or dementia
Donald A. Smith, MD, MPH
Ann Intern Med. 2014;160(10):JC10. doi:10.7326/0003-4819-160-10-201405200-02010
ACP Journal Club |  20 May 2014
Review: Statins are not associated with cognitive impairment or dementia in cognitively intact adults
Donald A. Smith, MD, MPH
Ann Intern Med. 2014;160(10):JC11. doi:10.7326/0003-4819-160-10-201405200-02011
ACP Journal Club |  17 December 2013
Fixed-dose combination pills reduced SBP and LDL-C in patients with, or at high risk for, cardiovascular disease
Paul Shekelle, MD
Ann Intern Med. 2013;159(12):JC9. doi:10.7326/0003-4819-159-12-201312170-02009
ACP Journal Club |  19 November 2013
Review: Antipsychotic drugs improve symptoms, with different levels of side effects, in schizophrenia
Adrian Preda, MD
Ann Intern Med. 2013;159(10):JC7. doi:10.7326/0003-4819-159-10-201311190-02007
ACP Journal Club |  16 July 2013
Review: Statins reduce mortality and major vascular events in patients with no history of CV disease
C. Raina Elley, MD
Ann Intern Med. 2013;159(2):JC2. doi:10.7326/0003-4819-159-2-201307160-02002
ACP Journal Club |  16 July 2013
Meta-analysis: Atorvastatin reduces CV events and increases new-onset diabetes in patients with coronary disease
Sanjum S. Sethi, MD; Michael E. Farkouh, MD, MSc
Ann Intern Med. 2013;159(2):JC3. doi:10.7326/0003-4819-159-2-201307160-02003
ACP Journal Club |  18 December 2012
Review: Omega-3 polyunsaturated fatty acid supplements do not reduce major cardiovascular events in adults
Donald A. Smith, MD, MPH, FACP, FNLA
Ann Intern Med. 2012;157(12):JC6-5. doi:10.7326/0003-4819-157-12-201212180-02005
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.